A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: The role of sentinel node biopsy and positron emission tomography

Oral Oncology

Volumn 39, Issue 4, 2003, Pages 350-360

  Hyde, N C ^a   Prvulovich, E ^b   Newman, L ^c   Waddington, W A ^b   Visvikis, D ^b   Ell, P ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Metastases; Oral carcinoma; Positron emission tomography; Sentinel node

Indexed keywords

ALBUMIN TC 99M; DISULFINE BLUE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SURGERY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; IMAGING; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; NECK DISSECTION; NECK METASTASIS; ORAL BIOPSY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

EID: 0037409226     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(02)00121-5     Document Type: Article

References (52)

1. Johnson N.W. Orofacial neoplasms, global epidemiology, risk factors and recommendations for research. Int Dent J. 41:1991;365-375.
2. Cancer Research Campaign fact sheet 1.1; 1994.
3. Johnson N.W., Warnakulasuriya K.A.A.S. Epidemiology and aetiology of oral cancer in the United Kingdom. Comm Dent Health. 10(suppl):1993;13-29.
4. Hindle I., Downer M.C., Speight P.M. Oral cancer in England and Wales 1901-1990. Br J Oral Maxillofac Surg. 34:1996;471-476.
5. Brown A.E., Langdon J.D. Management of oral cancer. Ann R Coll Surg Engl. 77:1995;404-408.
6. Shah J.P. Patterns of cervical lymph node metastases from squamous cell carcinomas of the upper aerodigestive tract. Am J Surg. 160:1990;405-409.
7. 0 neck. Arch Otolaryngol Head Neck Surg. 120:1994;699-702.
8. Hughes C.J., Gallo O., Spiro R.H.et al. Management of occult neck metastases in oral cavity squamous carcinoma. Am J Surg. 166:1993;380-383.
9. Byers R.M., El Naggar A.K., Lee Y.Y.et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck Surg. 20:1998;138-144.
10. 0 neck. Br J Oral Maxillofac Surg. 37:1999;205-209.
11. 0 neck. Am J Surg. 172:1996;689-691.
12. 0 neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Clin North Am. 31:1998;803-813.
13. Grandi C., Alloisio M., Moglia D.et al. Prognostic significance of lymphatic spread in head and neck carcinomas. therapeutic implications Head Neck Surg. 8:1985;67-73.
14. Piedbos P., Mazeron J.J., Haddad E. Stage I-II squamous cell carcinoma of the oral cavity treated by irridium 192. Is elective neck dissection indicated? Radiother Oncol. 21:1991;100-106.
15. Yuen A.P.W., Wei I.W., Wong Y.M., Tang C.T. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck Surg. 19:1997;583-588.
16. 0 tongue tumours undergoing a prophylactic neck dissection. Head Neck Surg. 21:1999;517-525.
17. Van den Brekel M.W.M., Castelijns J.A., Snow G.B. Diagnostic evaluation of the neck. Otolaryngol Clin N Am. 31:1998;601-619.
18. Hildmann H., Kosberg R.D., Tiedjen K.U. Lymphoscintigraphic studies of regional lymph vessels in patients with head and neck tumours. HNO. 35:1987;31-33.
19. Charron M., Mochizuki T., Levine G., Tauxe W.N. Lymphoscintigraphy in the detection of cervical metastases from oral carcinoma. a pilot study Ann R Coll Surg Engl. 74:1992;436-445.
20. Sri-Pathmanathan R., Railton R. Lymphoscintigraphy in the detection of cervical metastases from oral carcinoma. a pilot study [letter] Ann R Coll Surg Engl. 74:1992;436.
21. Terui S., Terauchi T., Ebihara S., Yoshizumi T.et al. Lymphoscintigraphy of head and neck cancer. Angiology. 43:1992;925-932.
22. Klutmann S., Bohuslavizki K.H., Brenner W., Hoft S.et al. Lymphoscintigraphy in tumours of the head and neck using double tracer technique. J Nucl Med. 40:1999;776-782.
23. Byers R.M., Weber R.S., Andrews T.et al. Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck. 19:1997;14-19.
24. Woolgar J.A. Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas. Br J Oral Maxillofac Surg. 37:1999;175-180.
25. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 29:1972;1446-1450.
26. Alex J.C., Krag D.N. The gamma probe guided resection of radiolabelled primary lymph nodes. Surg Oncol Clin N Am. 5:1996;33-41.
27. Pitman K.T., Johnson J.T., Edington H., Barnes E.L.et al. Lymphatic mapping with isosulphan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 124:1998;790-793.
28. Shoaib T., Soutar D.S., Prosser J.E., Dunaway D.J.et al. A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck. 21:1999;728-733.
29. Meijer S., van den Brekel M.W., Nieuwenhuis E.J. A suggested method for sentinel node biopsy in SCC of the head and neck. Head Neck. 22:2000;733-735.
30. Werner J.A., Dunne A.A., Brandt D., Ramaswamy A.et al. Studies on significance of sentinel lymphadenectomy in pharyngeal and laryngeal carcinoma. Laryngorhinootologie. 78:1999;663-670.
31. 2 oral cavity tumors? In: Proceedings and Abstracts, European Journal of Nuclear Medicine, 1st International Congress on Sentinel Node in Diagnosis and Treatment of Cancer, Amsterdam; 1999.
32. Mamelle G. Selective neck dissection and sentinel node biopsy in head and neck squamous cell carcinomas. Recent Results in Cancer Research. 157:2000;193-200.
33. 0 tongue tumors? Surgery. 128:2000;16-21.
34. Alex J.C., Sasaki C.T., Krag D.N., Wenig B.et al. Sentinel lymph node radiolocalisation in head and neck squamous cell carcinoma. Laryngoscope. 110:2000;198-203.
35. 0 neck. Cancer. 91:2001;2077-2083.
36. Alex J.C., Krag D.N., Harlow S.P., Meijer S.et al. Localisation of regional lymphatics in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg. 124:1998;135-140.
37. Carlson G.W., Murray D.R., Greenlee R., Alazraki N.et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg. 126:2000;433-437.
38. Koch W.M., Choti M.A., Civelek A.C., Eisele D.W.et al. Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 124:1998;455-459.
39. Wong W.L., Chevretton E.B., McGurk M., Hussain K.et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol. 22:1997;209-214.
40. Laubenbacher C., Saumweber D., Wagner-Manslau C., Kau R.J.et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI, and endoscopy for staging head and neck squamous cell carcinomas. J Nucl Med. 36:1995;1747-1757.
41. 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 25:1998;1255-1260.
42. Benchaou M., Lehman W., Slosman D.O.et al. The role of FDG PET in the pre-operative assessment of N staging in head and neck cancer. Acta Otolaryngol. 116:1996;332-335.
43. 0 neck. Laryngoscope. 108:1998;232-236.
44. Braams J.W., Pruim J., Freling N.J.M., Nikkels P.G.et al. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG PET and MRI. J Nucl Med. 36:1995;211-216.
45. Rege S., Maass A., Chaiken L.et al. Use of positron emission tomography with fluorodeoxyglucose in patints with extracranial head and neck cancers. Cancer. 73:1994;3047-3058.
46. McGuirt W.F., Williams D.W., Keyes J.W., Greven K.M.et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope. 105:1995;373-375.
47. Stokkel M.P.M., ten Broek F.-W., Hordijk G.-J., Koole R.et al. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18 fluorodeoxyglucose positron emission tomography. Ann Surg. 231:2000;229-234.
48. Stuckensen T., Kovacs A.F., Adams S., Baum R.P. Staging the neck in patients with oral cavity squamous cell carcinomas, a prospective comparison of PET, ultrasound, CT and MRI. J Cranio-Maxillofac Surg. 28:2000;319-324.
49. Rinne D., Baum R.B., Hor G.et al. Primary staging and follow-up of high risk melanoma patients with whole body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer. 82:1998;1664-1667.
50. Crippa F., Leutner M., Belli F., Gallino F.et al. Which kinds of lymph node metastases can FDG-PET detect? A clinical study in melanoma. J. Nucl. Med. 41:2000;1491-1494.
51. Don D.M., Anzai Y., Lufkin R.B.et al. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope. 105:1995;669-674.
52. Woolgar J.A. Micrometastases in oral/oropharyngeal squamous cell carcinoma, incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg. 37:1999;181-186.